WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences and Substance Abuse, Department of Psychiatry, University of Ibadan, Ibadan, Nigeria.
Department of Behavioural Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Lancet. 2020 Aug 29;396(10251):612-622. doi: 10.1016/S0140-6736(20)30634-6.
Traditional and faith healers (TFH) provide care to a large number of people with psychosis in many sub-Saharan African countries but they practise outside the formal mental health system. We aimed to assess the effectiveness and cost-effectiveness of a collaborative shared care model for psychosis delivered by TFH and primary health-care providers (PHCW).
In this cluster-randomised trial in Kumasi, Ghana and Ibadan, Nigeria, we randomly allocated clusters (a primary care clinic and neighbouring TFH facilities) 1:1, stratified by size and country, to an intervention group or enhanced care as usual. The intervention included a manualised collaborative shared care delivered by trained TFH and PHCW. Eligible participants were adults (aged ≥18 years) newly admitted to TFH facilities with active psychotic symptoms (positive and negative syndrome scale [PANSS] score ≥60). The primary outcome, by masked assessments at 6 months, was the difference in psychotic symptom improvement as measured with the PANSS in patients in follow-up at 3 and 6 months. Patients exposure to harmful treatment practices, such as shackling, were also assessed at 3 and 6 months. Care costs were assessed at baseline, 3-month and 6-month follow-up, and for the entire 6 months of follow-up. This trial was registered with the National Institutes of Health Clinical Trial registry, NCT02895269.
Between Sept 1, 2016, and May 3, 2017, 51 clusters were randomly allocated (26 intervention, 25 control) with 307 patients enrolled (166 [54%] in the intervention group and 141 [46%] in the control group). 190 (62%) of participants were men. Baseline mean PANSS score was 107·3 (SD 17·5) for the intervention group and 108·9 (18·3) for the control group. 286 (93%) completed the 6-month follow-up at which the mean total PANSS score for intervention group was 53·4 (19·9) compared with 67·6 (23·3) for the control group (adjusted mean difference -15·01 (95% CI -21·17 to -8·84; 0·0001). Harmful practices decreased from 94 (57%) of 166 patients at baseline to 13 (9%) of 152 at 6 months in the intervention group (-0·48 [-0·60 to -0·37] p<0·001) and from 59 (42%) of 141 patients to 13 (10%) of 134 in the control group (-0·33 [-0·45 to -0·21] p<0·001), with no significant difference between the two groups. Greater reductions in overall care costs were seen in the intervention group than in the control group. At the 6 month assessment, greater reductions in total health service and time costs were seen in the intervention group; however, cumulative costs over this period were higher (US $627 per patient vs $526 in the control group). Five patients in the intervention group had mild extrapyramidal side effects.
A collaborative shared care delivered by TFH and conventional health-care providers for people with psychosis was effective and cost-effective. The model of care offers the prospect of scaling up improved care to this vulnerable population in settings with low resources.
US National Institute of Mental Health.
在许多撒哈拉以南非洲国家,传统和信仰治疗师(TFH)为大量患有精神病的人提供护理,但他们的治疗活动在正规的精神卫生系统之外进行。我们旨在评估由 TFH 和初级卫生保健提供者(PHCW)共同提供的精神分裂症协作共享护理模式的效果和成本效益。
在加纳库马西和尼日利亚伊巴丹的这项集群随机试验中,我们按照规模和国家将集群(一个初级保健诊所和附近的 TFH 设施) 1:1 随机分配到干预组或强化常规护理。干预措施包括由经过培训的 TFH 和 PHCW 提供的协作共享护理手册。符合条件的参与者是新被诊断为 TFH 设施中患有活跃精神病症状(阳性和阴性症状量表[PANSS]评分≥60)的成年人(年龄≥18 岁)。主要结局是在 3 个月和 6 个月随访时,通过盲法评估,随访患者的 PANSS 评分中精神病症状改善的差异。还在 3 个月和 6 个月评估患者是否接触到有害的治疗方法,例如束缚。在基线、3 个月和 6 个月随访时评估护理费用,并在整个 6 个月的随访期间进行评估。该试验在国立卫生研究院临床试验注册处(NCT02895269)进行了注册。
2016 年 9 月 1 日至 2017 年 5 月 3 日期间,随机分配了 51 个集群(26 个干预组,25 个对照组),共有 307 名患者入组(干预组 166[54%],对照组 141[46%])。190 名(62%)参与者为男性。干预组的基线平均 PANSS 评分为 107.3(SD 17.5),对照组为 108.9(18.3)。286 名(93%)完成了 6 个月的随访,干预组的平均总 PANSS 评分为 53.4(19.9),而对照组为 67.6(23.3)(调整后的平均差异-15.01(95%CI-21.17 至-8.84;0.0001)。有害行为从基线时 166 名患者中的 94 名(57%)减少到干预组 6 个月时的 13 名(9%)(-0.48[-0.60 至-0.37]p<0.001),从对照组 141 名患者中的 59 名(42%)减少到 13 名(10%)(-0.33[-0.45 至-0.21]p<0.001),两组之间没有显著差异。干预组的整体护理成本减少幅度更大。在 6 个月的评估中,干预组的总医疗服务和时间成本减少幅度更大;然而,在此期间累积成本更高(每个患者 627 美元,对照组为 526 美元)。干预组有 5 名患者出现轻度锥体外系副作用。
由 TFH 和常规医疗保健提供者为精神病患者提供的协作共享护理是有效且具有成本效益的。这种护理模式为在资源匮乏的环境中为这一弱势群体提供改善的护理提供了前景。
美国国家心理健康研究所。